Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
In their editorial on why Britain's drug czar must not wage war
on drugs Strang et al strongly advocate a pragmatic approach by the
government to the national and international drug problem.1 In doing so they seem keen to protect the
relative medical autonomy in treatment of addicts afforded by the
"British system."2 They call for a maintained emphasis
on evidence based treatment, rehabilitation, and preventive strategies
and quote the success of the needle and syringe exchanges, as well as
the tolerance of injectable heroin and methadone prescribing, as
examples of this pragmatic approach.
As well as advantages, however, there are surely disadvantages afforded
by a system largely devoid of regulation. The most frequently expressed
concern is that of widespread diversion of prescribed drugs to the
black market.3 As a profession, we seem to be doing little
to rebuff such criticism. The recently published results from a survey